Nuclear Cardiology Today
Learners will participate in live and pre-recorded sessions reviewing the latest advances in SPECT and PET imaging and providing practical insights into running an efficient, productive nuclear cardiology laboratory.
"Strategies to Thrive in a Changing Healthcare Environment"
April 29 - May 2
Longtime Nuclear Cardiology Today Program Co-chairs David Wolinsky, MD, MASNC, and Dennis Calnon, MD, MASNC, are joined by new event Co-chairs Renee Bullock-Palmer, MD, FASNC, and Rupa M. Sanghani, MD, FASNC.
This program provides attendees with practical knowledge and expert perspectives on the delivery of high-value nuclear cardiology services in the evolving healthcare environment. A key feature of the program is addressing everyday practice dilemmas that arise in the nuclear lab. The case-based approach to disease management equips participants to demonstrate the value of nuclear cardiology to their administrators and referring physicians.
The course will provide 15* AMA PRA Category 1 Credits™ and 15* ARRT Category A credits**.
*Credits subject to change. **CE only obtainable with Technologist registration.
|Thursday, April 29|
|4:30 pm – 6:00pm||Visits Virtual Booths|
|6:00 pm||Welcome and Introduction to the Meeting||Drs. Calnon and Wolinsky|
|Session 1. Striving for Equity in Management of the Leading Causes of Death in 2020: Cardiovascular Diseases and COViD-19”|
|6:10 pm||Keynote Lecture: Addressing Healthcare Disparities in Cardiovascular Disease||Clyde Yancy, MD|
|6:55 pm||Keynote Lecture: “COVID-19 Update – Equity and Impact on Disproportionately Affected Populations”||Kristie Clarke, MD|
|7:40 pm||Panel Discussion – Virtual presentation|
|Friday, April 30|
|4:30 pm -6:00 pm||Visit Virtual Booths|
|Session 2. State of the Art of Cardiac Imaging in 2021|
|6:00 pm||Welcome and Key Points from Day 1||Drs. Calnon and Wolinsky|
|6:05 pm||Evolution of Evidence in Cardiac Testing||James Udelson, MD|
|6:50 pm||How do MPI and CTA live together in 2021?||Prem Soman, MD, PhD|
|7:35 pm||How will cardiac imaging evolve over the next 5 years?||Faculty and Participants|
|8:00 pm||Reception - Industry|
|Saturday, May 1|
|8:00 am||Visit Exhibit Booths|
|Session 3: Cardiac SPECT – Optimizing Performance||Moderators: Dr. Bullock-Palmer|
|9:00 am||Welcome and Goals for Day 3|
|9:05 am||How to Recognize and Prevent Artifacts||James Case, PhD|
|9:25 am||Integrating Non-Perfusion Data||Rami Doukky, MD|
|9:45 am||Interactive cases – Getting the Most Out of a Not So Perfect Study||Drs. Bullock-Palmer + Doukky + Case|
|10:15 am||Break – Visit Exhibit Booths|
|Session 4: Cardiac PET in Real-World Practice||Moderator: Dr. Sanghani|
|10:30 am||Clinical Value of PET||Dennis Calnon, MD|
|10:50 am||Quality Control = Quality Performance||James Case, PhD|
|11:10 am||Guiding Management Decisions with MBF/MBFR – Interactive Case Studies||Marcelo Di Carli, MD|
|12:00||Break – Visit Exhibit Booths|
|Session 5: Image Guided Disease State Management in a Changing Healthcare Environment||Moderator: Dr. Calnon|
|12:30 pm||CAC and the Power of Zero; Can we use CAC for Symptomatic Patients?||Khurram Nasir, MD|
|1:00 pm||Looking Beyond Appropriate Use to Appropriateness in Clinical Practice||David Wolinsky, MD|
|1:20 pm||The Many Faces of Heart Failure and the Role of Cardiac Imaging||Saurabh Malhotra, MD|
|1:40 pm||Role of Myocardial Viability in Real World Practice||Rob Beanlands, MD|
|2:00 pm||Evaluating patients with Tc-99m PYP: Don’t Prescribe the Wrong Drug Because of a Poor Test||David Wolinsky, MD|
|2:20 pm||Interactive Tc-99m PYP Cases||David Wolinsky, MD and Prem Soman, MD, PhD|
|3:00 pm||Break – Visit Exhibit Booths|
|Session 6: Expanding the Horizon in a Changing Healthcare Environment||Moderator: Renee Bullock-Palmer, MD|
|3:20 pm||Coronary Microvascular Disease: From Mystery to Reality||Rupa Sanghani, MD|
|3:40 pm||Cardiac Sarcoidosis: Clinical utility of FDG PET||Panithaya Chareonthaitawee, MD|
|4:00 pm||Challenging Cases in Nuclear Cardiology||Wael Jaber, MD|
|Sunday, May 2|
|8:00 am||Visit Virtual Booths|
|Session 7: Health Policy and Advocacy Efforts by ASNC||Moderator: Dennis Calnon, MD|
|8:30 am||Your ASNC at Work – Navigating Impediments to the Practice of Nuclear Cardiology||Drs. Wolinsky and Thompson|
|Session 8: Practical Dilemmas in Nuclear Cardiology – Using What you Have Learned||Moderators: Drs. Wolinsky and Calnon|
|9:15 am||Is the Test Normal, Borderline, or Mildly Abnormal? What are the Implications for How you Report the Study||Renee Bullock-Palmer, MD|
|9:30 am||The Patient Reaches Target Heart Rate at 1 Minute of Exercise Due to Severe Deconditioning and Anxiety: Is This an Adequate Stress for MPI?”||Randy Thompson, MD|
|9:45 am||What Does it Mean if the Myocardial Blood Flow Reserve is Abnormal Because Resting MBF is Elevated? Should We Report Corrected MBFR or Peak Stress MBF?||Marcelo Di Carli, MD|
|10:00 am||If the Regadenoson Dose Infiltrates, Can the Dose Be Repeated as Soon as IV Access Is Achieved?||Dennis Calnon, MD|
|10:15 am||What if There is No Flow Augmentation With Vasodilator Stress? What Do We Do?||Randy Thompson, MD|
|10:30 am||How Do I Manage a Grade 1 Tc-99m PYP Scan? Biopsy? Repeat the Test in A Year? Treat Empirically?||Jamie Bourque, MD|
|10:45 am||Break – Visit Virtual Booths|
|11:00 am||Ischemic Testing with MPI in Hypertrophic Cardiomyopathy: Is There Value?||Prem Soman, MD, PhD|
|11:15 am||What to Do With the Patient Who Can’t Lay Flat or Stay Still||Renee Bullock-Palmer, MD|
|11:30 am||Should Tc-99m PYP Be Done Routinely Pre-TAVR? If Tc-99m PYP is Positive, Should We Proceed With TAVR?||David Wolinsky, MD|
|11:45 am||Stress-first SPECT Shows a Clear Defect in a Patient with No Prior CAD; Get the Resting Image or Straight to the Cath Lab?||Dennis Calnon, MD|
|12:00 pm||New Onset Systolic Dysfunction: Can Ischemic Cardiomyopathy Be Excluded With Cardiac Imaging? Do All Patients Need A Catheterization?||Rupa Sanghani, MD|
|12:15 pm||Is CTA the Best Test for CAD Assessment with LBBB?||Renee Bullock-Palmer, MD|
|12:30 pm||The Stress EKG is Markedly Abnormal, Perfusion Scan is Normal, and the Patient is Asymptomatic – What Recommendation Do You Give to the Referring Doctor?||Jamie Bourque, MD|
|12:45 pm||Patient has LBBB and Referred for SPECT MPI but Reports Recent Hospitalization for Seizures||Renee Bullock-Palmer, MD
|1:00||Closing Remarks and Adjourn|
Save with early registration rates! Members save even more.
Not yet a member? Join ASNC today.
|Registration Type||Early Registration Rates
Through March 31
|Advanced Registration Rates
April 1 - April 29
|Member Physician (US and International)||
|Nonmember Physician (US and International)||
|Member: Technologist, International Emerging Markets, Fellow-in-Training||
Dennis A. Calnon, MD, MASNC
David G. Wolinsky, MD, MASNC
Renee Bullock-Palmer, MD, FASNC
Rupa M. Sanghani, MD, FASNC
“Attendees appreciate that they can bring their questions and problems—the things that are keeping them up at night—to NC Today and take home solutions that have worked for our renowned faculty as well as for attendees from labs a lot like theirs.” -Dr. Wolinsky, NC Today co-chair
This program will increase learners’ competence in solving technical and clinical issues facing imaging professionals running nuclear cardiology laboratories. The case-based approach to disease management equips participants to demonstrate the value of nuclear cardiology to their administrators and referring physicians. The Health Policy sessions provide an update regarding the latest changes in policy and reimbursement that impact the contemporary nuclear cardiology laboratory. The Practical Dilemma sessions provides attendees with the opportunity to understand how the expert faculty deal with many of the common problems encountered in everyday practice where no evidence-based clinical guidelines exist.
Describe recent advances in cardiac single photon emission computed tomography (SPECT) acquisition, processing and interpretation, and how they impact clinical practice
Define ways to avoid image artifacts with SPECT imaging
Characterize non-imaging abnormalities associated with pharmacologic stress testing
Summarize recent advances in positron emission tomography (PET) technology
Differentiate CTFFR from PET with myocardial blood flow
Employ optimal methodology to interpret and report nuclear cardiology studies
Determine the impact of MACRA/MIPS on value-based care
Evaluate the role of coronary calcium scoring in managing patients with CAD
Compare and contrast the roles of anatomic and physiologic imaging in patients with CAD
Integrate appropriate use criteria into test decision process
As an accredited provider of the Accreditation Council for Continuing Medical Education (ACCME), The American Society of Nuclear Cardiology (ASNC) adheres to the ACCME’s Standards for Commercial Support. In compliance with these standards, it is ASNC’s policy to ensure balance, independence, objectivity, and scientific merit in all of its educational activities through the disclosure of relevant financial relationship with commercial companies and resolution of conflicts of interest. The financial interest or relationships requiring disclosure are outlined in ASNC’s CME Conflict of Interest Policy. All planners, reviewers and presenters involved with this activity were required to disclose any relevant financial relationships.
The American Society of Nuclear Cardiology has reviewed this activity’s faculty disclosures and resolved or managed all identified conflicts of interest.
ASNC has received the highest level of recognition, Accreditation with Commendation, from the Accreditation Council for Continuing Medical Education (ACCME). Accreditation with Commendation is awarded to CME providers that demonstrate compliance in all aspects of accreditation requirements and for demonstrating exemplary engagement with the environment in support of physician learning and physician quality improvement.
Cancellation Policy: The registration fee is partially refundable if you cancel your registration by 11:59pm EST four weeks before the event. Any cancellation made four weeks before the event is subject to a $100 administration fee. Any cancellation after this deadline will not result in any refund. Notification of cancellation must be received in writing to ASNC. Please allow three weeks for processing. Telephone cancellations are not eligible for a refund, and no refunds will be issued after the cancellation deadline. Refunds will not be processed for no-shows. One-day registrations are non-refundable. The registration fees for all sessions and events are non-refundable and non-transferable to another participant, session or event.